For those with blood disorders like thrombocytopenia (low platelet count) or von Willebrand disease , bruising risks are significantly higher
ALDH4A1 gene mutation and epilepsy The ALDH4A1 gene, located at 1p36.13, encodes delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH)
Sources of information most influenced the decision to take GLP-1 medication: Doctor/healthcare provider: 65% Online research: 41% Friends or family: 37% Social media: 35% Influencer or celebrity endorsements: 18% News media (articles, TV, etc.): 10% 86% of people taking GLP-1 medication feel more in control of their diet since starting the treatment
Adding Victoza to insulin therapy in people with type 1 also led to an increased risk of low blood sugar (hypoglycemia), however
The global gap in treatment coverage for major depressive disorder in 84 countries from 20002019: A systematic review and Bayesian meta-regression analysis
Variability of human hepatic UDP-glucuronosyltransferase activity